Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Atyr Pharma Inc (ATYR)

Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 316,461
  • Shares Outstanding, K 83,942
  • Annual Sales, $ 350 K
  • Annual Income, $ -50,390 K
  • EBIT $ -63 M
  • EBITDA $ -63 M
  • 60-Month Beta 1.07
  • Price/Sales 813.26
  • Price/Cash Flow N/A
  • Price/Book 3.98

Options Overview Details

View History
  • Implied Volatility 138.12% ( -84.56%)
  • Historical Volatility 70.22%
  • IV Percentile 60%
  • IV Rank 18.20%
  • IV High 649.84% on 07/03/24
  • IV Low 24.24% on 08/22/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 500
  • Volume Avg (30-Day) 136
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 3,971
  • Open Int (30-Day) 3,367

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.22
  • Number of Estimates 3
  • High Estimate -0.19
  • Low Estimate -0.24
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +12.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.98 +22.99%
on 12/13/24
3.98 -7.91%
on 12/27/24
+0.22 (+6.54%)
since 11/27/24
3-Month
1.67 +119.46%
on 10/01/24
3.98 -7.91%
on 12/27/24
+1.89 (+107.06%)
since 09/27/24
52-Week
1.38 +165.58%
on 12/29/23
3.98 -7.91%
on 12/27/24
+2.19 (+149.32%)
since 12/27/23

Most Recent Stories

More News
aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ATYR : 3.68 (-2.39%)
aTyr Pharma Appoints Eric Benevich to Board of Directors

aTyr Pharma appoints Eric Benevich to its Board of Directors, enhancing commercialization efforts with his extensive industry experience.Quiver AI SummaryaTyr Pharma, Inc. announced the appointment of...

ATYR : 3.68 (-2.39%)
aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors

ATYR : 3.68 (-2.39%)
aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FITâ„¢ Study in Pulmonary Sarcoidosis

ATYR : 3.68 (-2.39%)
aTyr Pharma to Present Findings on ATYR0101 as a Novel Anti-Fibrotic Candidate at Keystone Symposia on Fibrosis

aTyr Pharma will present findings on its anti-fibrotic candidate ATYR0101 at the Keystone Symposia in December 2024.Quiver AI SummaryaTyr Pharma, Inc. announced that it will present two posters on its...

ATYR : 3.68 (-2.39%)
aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis

ATYR : 3.68 (-2.39%)
aTyr Pharma to Present Research on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis

aTyr Pharma announces poster presentations on tRNA synthetase candidate ATYR0101 at the upcoming Keystone Symposia on Fibrosis.Quiver AI SummaryaTyr Pharma, Inc. announced that it will present two posters...

ATYR : 3.68 (-2.39%)
aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis

ATYR : 3.68 (-2.39%)
Atyr Pharma: Q3 Earnings Snapshot

Atyr Pharma: Q3 Earnings Snapshot

ATYR : 3.68 (-2.39%)
aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update

ATYR : 3.68 (-2.39%)

Business Summary

aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.

See More

Key Turning Points

3rd Resistance Point 4.36
2nd Resistance Point 4.06
1st Resistance Point 3.92
Last Price 3.68
1st Support Level 3.48
2nd Support Level 3.18
3rd Support Level 3.04

See More

52-Week High 3.98
Last Price 3.68
Fibonacci 61.8% 2.99
Fibonacci 50% 2.68
Fibonacci 38.2% 2.37
52-Week Low 1.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar